PR Newswire (Thu, 1:00PM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
4,688 people get CVS articles and Market Currents by email alert.
Get email alerts on CVS »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
-
-
PR Newswire (May 14, 2013)
-
PR Newswire (May 14, 2013)
-
PR Newswire (May 13, 2013)
-
-
-
PR Newswire (May 9, 2013)
-
-
-
PR Newswire (May 1, 2013)
-
-
PR Newswire (Apr 30, 2013)
-
Regulation To Drive Pharmacy SpecializationTom Luongo • Fri, Apr 26
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
Why We Like CVS CaremarkUlfberht Capital • Mon, Apr 8 -
-
-
-
-
-
-
-
-
-
Earnings Analysis: CVS CaremarkCapitalCube • Wed, Nov 7, 2012 -
Watch For Walgreen-Express Scripts Impact In CVS Caremark EarningsTrefis • Mon, Nov 5, 2012
-
-
-
-
-
CVS: Demographics And Business Model Mean Tons Of Upside For The StockMike Williams • Thu, Aug 16, 2012
-
CVS Caremark's CEO Hosts 2012 Analyst Day (Transcript)Thu, Dec 13, 2012
-
CVS Caremark's CEO Discusses Q4 2011 Results - Earnings Call TranscriptWed, Feb 8, 2012 • 1 Comment
-
CVS Caremark Corporation - Analyst/Investor DayTue, Dec 20, 2011
-
CVS Caremark's CEO Discusses Q3 2011 Results - Earnings Call TranscriptThu, Nov 3, 2011 • 1 Comment
-
CVS Caremark Corporation Q2 2010 Earnings Call TranscriptThu, Jul 29, 2010
-
CVS Caremark Q1 2010 Earnings Call TranscriptTue, May 4, 2010
-
CVS Caremark Corporation Q4 2009 Earnings Call TranscriptMon, Feb 8, 2010
-
CVS Caremark Q3 2009 Earnings Call TranscriptThu, Nov 5, 2009
-
CVS Caremark Q2 2009 Earnings Call TranscriptTue, Aug 4, 2009
-
CVS Caremark Corporation Q1 2009 Earnings Call TranscriptTue, May 5, 2009
-
PR Newswire (Thu, 1:00PM)
-
PR Newswire (May 14, 2013)
-
PR Newswire (May 14, 2013)
-
PR Newswire (May 13, 2013)
-
at Fox Business (May 13, 2013)
-
PR Newswire (May 9, 2013)
-
at MarketWatch.com (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
at Fox Business (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
PR Newswire (May 1, 2013)
-
at CNBC.com (Apr 30, 2013)
-
PR Newswire (Apr 30, 2013)
-
at MarketWatch.com (Apr 28, 2013)
-
at CNBC.com (Apr 26, 2013)
-
at CNBC.com (Apr 20, 2013)
CVS vs. ETF Alternatives
Company Description
CVS Caremark Corporation (“CVS Caremark”, the “Company”, “we” or “us”) is the largest pharmacy health care provider in the United States. As a fully integrated pharmacy services company, we believe we can drive value for our customers by effectively managing pharmaceutical costs and improving... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Tuesday, November 6, 2012, 7:03 AM CVS Caremark (CVS): Q3 EPS of $0.85 beats by $0.01. Revenue of $30.2B (+13.3% Y/Y) misses by $700M. (PR) Comment! [Earnings]
- Tuesday, November 6, 2012, 12:05 AM Notable earnings before Tuesday’s open: AKRX, AMED, AMSC, AOL, CPN, CRIS, CRZO, CSC, CVC, CVS, DISCA, DISH, DNR, DTV, DWRE, EMR, EXPD, FOSL, FTR, FUN, GEL, HCN, HL, HPT, ISIS, KWK, MFA, NYX, ODP, OMX, OXF, POM, SCG, SRE, VVUS 1 Comment [Earnings]
- Monday, November 5, 2012, 5:30 PM Notable earnings before Tuesday’s open: AKRX, AMED, AMSC, AOL, CPN, CRIS, CRZO, CSC, CVC, CVS, DISCA, DISH, DNR, DTV, DWRE, EMR, EXPD, FOSL, FTR, FUN, GEL, HCN, HL, HPT, ISIS, KWK, MFA, NYX, ODP, OMX, OXF, POM, SCG, SRE, VVUS Comment! [Earnings]
- Tuesday, October 30, 2012, 11:38 AM Are Halloween candy sales at risk of being muted this year? As trick-or-treating gets delayed up and down the Eastern Seaboard the estimated $2.4B boom in candy sales in front of the holiday could come in light this year. Analysts say it won't be candy manufacturers that take the hit with stores already loaded up, but drugstore chains such as Walgreen (WAG), CVS Caremark (CVS), and Rite Aid (RAD) could see a disappointing holiday haul. 1 Comment [Consumer]
- Friday, October 12, 2012, 7:14 AM CVS Caremark (CVS) is reportedly under investigation from federal officials looking into if the company violated Medicare laws. One of the allegations is that the company routinely refilled prescriptions without receiving prior approval from patients. Comment! [Consumer]
- Wednesday, October 10, 2012, 10:29 AM Another tidbit from Wal-Mart's (WMT +2.8%) investor meeting (webcast): The company plans to have over 240 Neighborhood Market stores in place by the end of FY13, a significant pickup in the pace of growth for the small-sized supermarkets across the landscape. While posing an obvious threat to local and national grocery stores, the initiative could also effect pharmacy sales at Walgreen (WAG +0.1%), CVS Caremark (CVS +0.5%), and Rite Aid (RAD +0.4%) eventually. 4 Comments [Consumer]
- Wednesday, September 19, 2012, 3:58 PM With the stock at an all-time high, CVS Caremark (CVS +0.8%) announces board approval of a new repurchase program for up to $6B worth of the company's shares. (PR) 4 Comments [Healthcare, Breaking News]
- Wednesday, September 12, 2012, 8:19 AM The DEA has withdrawn the controlled substance registrations of two CVS Caremark (CVS) pharmacies in Florida after some retail locations experienced sharply higher sales of the addictive prescription painkiller oxycodone. The DEA says CVS and its wholesale suppler Cardinal Health should have realized that the sales increase was a sign that the drugs were be resold in the black market. 1 Comment [Healthcare]
- Tuesday, September 4, 2012, 11:51 AM The FTC says checks will soon be in the mail for 13K Medicare beneficiaries who were charged too much by CVS Caremark (CVS -0.1%) at pharmacies. Though the monetary hit is relatively minor for CVS, it's in the middle of trying to hit its forecast of retaining at least 50% of the Walgreen customers who it snapped up during the Express Scripps impasse. Comment! [Consumer]
- Tuesday, August 28, 2012, 12:30 PM A light flu season and increased competition over flu shots hit the bottom lines of drugstore chains last year, so this year they've decided to get an early jump to try to edge out retail players such as Wal-Mart and Target. CVS Caremark (CVS +0.5%), Walgreen (WAG -0.4%), and Rite Aid (RAD -0.5%) have all rolled out promotions aimed at getting customers into their pharmacies before the big boys catch the flu shot sale. 1 Comment [Consumer]
- Thursday, August 16, 2012, 9:39 AM Cantor Fitzgerald initiates both Walgreen (WAG -0.2%) and CVS Caremark (CVS +0.1%) with Buy ratings. While Walgreen is likely to benefit from the impact of acquisitions and generic drugs, CVS should see margin gains in retail and PBM operations this year, according to analyst Ajay Jain. Comment! [Consumer]
- Tuesday, August 14, 2012, 6:15 PM Bespoke posts tables of sell-side analysts' most loved and most hated S&P 500 stocks. Eight boast at least 90% Buy ratings: SLM, A, SLB, CVS, ATI, COV, FLR, EMC. Take analyst recommendations with a fistful of salt but they're at least a sentiment indicator; note "the most loathed stock of all" - Sears (SHLD) - is up more than 70% YTD. 5 Comments [Quick Ideas]
- Tuesday, August 14, 2012, 8:25 AM The FTC yesterday said pharmaceutical companies are delaying generic competition by making patent settlement agreements in which they pledge not to launch their own copycat medicines. The FTC made the comments in a case involving CVS and Rite Aid (RAD), which are suing Pfizer (PFE) and TEVA for conspiring to keep generic versions of the antidepressant Effexor XR out of stores. 4 Comments [Healthcare]
- Wednesday, August 8, 2012, 9:25 AM Shares of CVS Caremark (CVS) ride a timely upgrade from BMO Capital higher. Analysts cite increased earnings potential and less uncertainty on the impact of the Walgreen-Express Script dispute on results as they raise their rating on the drugstore chain to Outperform from Market Perform. CVS +1.1% premarket. Comment! [On the Move, Consumer]
- Tuesday, August 7, 2012, 7:25 AM More on CVS Caremark (CVS): Pharmacy Services sales up 28.2% Y/Y to $18.4B, led by new client starts and drug cost inflation. Retail Pharmacy 6.9% higher to $15.8B, with Walgreen-Express Scripts dispute impacting results. Raises and narrows full-year EPS to $3.32-$3.38, up from prior guidance of $3.23-$3.33. (PR) Comment! [Consumer, Earnings]
- Tuesday, August 7, 2012, 7:07 AM CVS Caremark (CVS): Q2 EPS of $0.81 beats by $0.02. Revenue of $30.7B misses by $270M. 5 Comments [Earnings]
-
- View all 0 replies
-
- View all 0 replies
-
ConservativeOutperformer
Very clean presentation by $CVS this morning. Breaking out the cash available to owners and goals for operations = Winning! - View all 1 replies
-
ConservativeOutperformer: Slide 16 of their Analyst Presentation is showing $22.5B in cash available for returns from '13 to '15. Thats, >33% the current mkt cap.
-
- View all 0 replies
-
- View all 0 replies
-
- View all 1 replies
-
-
- View all 3 replies
-
-
-
- View all 2 replies
-
Chines33: I think it goes to 50-52. Strong dollar aging population I the sweet spot
-
-
- View all 0 replies
-
- View all 1 replies
-
LATEST REPLIES